Pericardial tuberculosis
ICD-10 A18.8 · ICD-11 1B12.0

Treatment of Tuberculous Pericarditis Presenting as Effusive-Constrictive Pericarditis

When tuberculous pericarditis manifests as a combined effusive-constrictive pattern — simultaneous pericardial fluid accumulation and constrictive physiology — it represents a distinct clinical situation requiring a specific, structured management approach.

Clinical Scenario

Tuberculous pericarditis presents clinically in three forms: pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction. This protocol addresses the combined effusive-constrictive presentation, where both processes are active concurrently and the evolving pericardial anatomy must be closely followed.

Treatment Approach

Management centres on antituberculosis drug therapy alongside systematic echocardiographic surveillance to monitor changes in pericardial structure over time. The monitoring strategy is oriented toward detecting whether the pericardium develops anatomy that warrants a surgical intervention.

The complete regimen — including drug selection, sequencing, and the full criteria for surgical evaluation — is available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1161/circulationaha.105.543066

Tuberculous pericarditis presents clinically in 3 forms, namely, pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction.

Antituberculosis drugs should be given and serial echocardiography performed to detect the development of a pericardial skin that is amenable to surgical stripping.

A regimen consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol for at least 2 months, followed by isoniazid and rifampicin (total of 6 months of therapy) has been shown to be highly effective in treating patients with extrapulmonary TB.

View source ↗